Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil M Davies

Showing results (31-40 of 175) with videos related to

Pageof 18
Sort By:
Journal of Alzheimer'S Disease : JAD|June 29, 2011
Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementiasNeil M Davies, Patrick G Kehoe, Yoav Ben-Shlomo, et al.
Cold Spring Harbor Perspectives in Medicine|March 4, 2020
Integrating Family-Based and Mendelian Randomization DesignsLiang-Dar Hwang, Neil M Davies, Nicole M Warrington, et al.
Neurology. Genetics|November 14, 2025
Disentangling the Causal Effects of Education and Participation Bias on Alzheimer Disease Using Mendelian RandomizationAadrita Chatterjee, Clémence Cavaillès, Neil M Davies, et al.
BMJ Open|January 13, 2021
Causal effect of children's secondary education on parental health outcomes: findings from a natural experiment in BotswanaJan Ole Ludwig, Neil M Davies, Jacob Bor, et al.
Economics and Human Biology|July 8, 2022
Estimating the causal effect of liability to disease on healthcare costs using Mendelian RandomizationPadraig Dixon, Sean Harrison, William Hollingworth, et al.
International Journal of Epidemiology|July 24, 2019
Repurposing antihypertensive drugs for the prevention of Alzheimer's disease: a Mendelian randomization studyVenexia M Walker, Patrick G Kehoe, Richard M Martin, et al.
Brain, Behavior, & Immunity - Health|February 16, 2026
Assessing the repurposing potential of disease-modifying antirheumatic drug targets to reduce Alzheimer's disease risk: a Mendelian randomization studyChristina N Kushnir, Victoria Taylor-Bateman, Neil M Davies, et al.
Epidemiology (Cambridge, Mass.)|August 26, 2020
Comparison of Antihypertensive Drug Classes for Dementia PreventionVenexia M Walker, Neil M Davies, Richard M Martin, et al.
Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Disentangling the causal effects of education and participation bias on Alzheimer's disease using Mendelian RandomizationAadrita Chatterjee, Clémence Cavaillès, Neil M Davies, et al.
Plos Genetics|July 14, 2022
Polygenic and socioeconomic risk for high body mass index: 69 years of follow-up across lifeDavid Bann, Liam Wright, Rebecca Hardy, et al.
Pageof 18

Showing results (31-40 of 175) with videos related to

Sort By:
Pageof 18
Journal of Alzheimer'S Disease : JAD|June 29, 2011
Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementiasNeil M Davies, Patrick G Kehoe, Yoav Ben-Shlomo, et al.
Cold Spring Harbor Perspectives in Medicine|March 4, 2020
Integrating Family-Based and Mendelian Randomization DesignsLiang-Dar Hwang, Neil M Davies, Nicole M Warrington, et al.
Neurology. Genetics|November 14, 2025
Disentangling the Causal Effects of Education and Participation Bias on Alzheimer Disease Using Mendelian RandomizationAadrita Chatterjee, Clémence Cavaillès, Neil M Davies, et al.
BMJ Open|January 13, 2021
Causal effect of children's secondary education on parental health outcomes: findings from a natural experiment in BotswanaJan Ole Ludwig, Neil M Davies, Jacob Bor, et al.
Economics and Human Biology|July 8, 2022
Estimating the causal effect of liability to disease on healthcare costs using Mendelian RandomizationPadraig Dixon, Sean Harrison, William Hollingworth, et al.
International Journal of Epidemiology|July 24, 2019
Repurposing antihypertensive drugs for the prevention of Alzheimer's disease: a Mendelian randomization studyVenexia M Walker, Patrick G Kehoe, Richard M Martin, et al.
Brain, Behavior, & Immunity - Health|February 16, 2026
Assessing the repurposing potential of disease-modifying antirheumatic drug targets to reduce Alzheimer's disease risk: a Mendelian randomization studyChristina N Kushnir, Victoria Taylor-Bateman, Neil M Davies, et al.
Epidemiology (Cambridge, Mass.)|August 26, 2020
Comparison of Antihypertensive Drug Classes for Dementia PreventionVenexia M Walker, Neil M Davies, Richard M Martin, et al.
Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Disentangling the causal effects of education and participation bias on Alzheimer's disease using Mendelian RandomizationAadrita Chatterjee, Clémence Cavaillès, Neil M Davies, et al.
Plos Genetics|July 14, 2022
Polygenic and socioeconomic risk for high body mass index: 69 years of follow-up across lifeDavid Bann, Liam Wright, Rebecca Hardy, et al.
Pageof 18